Induction of apoptosis by idarubicin: How important is the plasma peak?

International Journal of Clinical Pharmacology and Therapeutics

Volumn 38, Issue 4, 2000, Pages 217-221

  Gieseler, F ^a,b   Clark, M ^a   Stiebeling, K ^a   Puschmann, M ^a   Valsamas, S ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Apoptosis; Idarubicin; Intracellular pharmacokinetic; Plasma peak

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; IDARUBICIN; IDARUBICINOL;

APOPTOSIS; AREA UNDER THE CURVE; ARTICLE; CARDIOTOXICITY; CELL VIABILITY; DNA BINDING; HUMAN; HUMAN CELL; LEUKEMIA CELL;

EID: 0034126376     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP38217     Document Type: Article

References (13)

1. Belloc F, Lacombe F, Dumain P, Lopez F, Bernard P, Boisseau MR, Reifers J 1992 Intercalation of anthracyclines into living cell DNA analyzed by flow cytometry. Cytometry 13: 880-885
2. Downes CS, Johnson RT 1988 DNA topoisomerases and DNA repair. Bioassays 8: 179-184
3. Gieseler F, Nüßler V, Brieden T, Kunze J, Valsamas S 1998 Intracellular pharmacokinetics of anthracyclines in human leukemia cells: correlation of DNA-binding with apoptotic cell death. Int J Pharmacol 36: 25-28
4. Goebel M 1993 Oral idarubicin an anthracycline derivative with unique properties. Ann Hematol 66: 33-43
5. Goebel M, Kaplan E 1992 Anthracycline-induced cardiotoxicity a review Onkologie 15: 198-204
6. Hershko C, Link G, Tzahor M, Pinson A 1993 The role of iron chelators in anthracycline cardiotoxicity. Leuk Lymphoma 11: 207-214
7. Hochster H, Wasserheit C, Speyer J 1995 Cardiotoxicity and cardioprotection during chemotherapy. Curr Opin Oncol 7: 304-309
8. Kuffel MJ, Reid MJ, Ames MM 1992 Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture. Cancer Chemother Pharmacol 30: 51-57
9. Larsen AK, Gobert C, Gilbert C, Markovits J, Bojanowski K, Skladanowski A 1998 DNA topoisomerases as repair enzymes: mechanism(s) of action and regulation by p53. Acta Biochim Pol 45: 535-544
10. Minotti G, Cairo G, Monti E 1999 Role of iron in anthracycline cardiotoxicity: new tunes for an old song? Faseb J 13: 199-212
11. Nelson WG, Kastan MB 1994 DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 14: 1815-1823
12. Page B, Page M, Noel C 1993 A new flourimetric assay for cytotoxicity measurements in vitro. Int J Oncol 3: 473-476
13. Robert J, Gianni L 1993 Pharmacokinetics and metabolism of anthracyclines. Cancer Surv 17: 219-252